Correlation Between Elutia and Tarsus Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elutia and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elutia and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elutia Inc and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Elutia and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elutia with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elutia and Tarsus Pharmaceuticals.

Diversification Opportunities for Elutia and Tarsus Pharmaceuticals

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Elutia and Tarsus is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Elutia Inc and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Elutia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elutia Inc are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Elutia i.e., Elutia and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Elutia and Tarsus Pharmaceuticals

Given the investment horizon of 90 days Elutia is expected to generate 1.24 times less return on investment than Tarsus Pharmaceuticals. In addition to that, Elutia is 1.32 times more volatile than Tarsus Pharmaceuticals. It trades about 0.05 of its total potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about 0.08 per unit of volatility. If you would invest  1,779  in Tarsus Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  3,045  from holding Tarsus Pharmaceuticals or generate 171.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Elutia Inc  vs.  Tarsus Pharmaceuticals

 Performance 
       Timeline  
Elutia Inc 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Elutia Inc are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Elutia may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Elutia and Tarsus Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elutia and Tarsus Pharmaceuticals

The main advantage of trading using opposite Elutia and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elutia position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.
The idea behind Elutia Inc and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance